MolPort-001-018-217

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

54 Suppliers, 34 USDMF, 15 CEP/COS, 6 EU WC, 27 NDC API, 20 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

3 Suppliers

3 Suppliers

DOSSIERs // Finished Dosage Forms

121 Dossiers, 70 FDA Orange Book, 18 Europe, 6 Canada, 6 Australia, 4 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 100MG, CAPSULE;ORAL - 25MG, CAPSULE;ORAL - 50MG, CAPSULE;ORAL - 75MG;25MG, SUSPENSION;ORAL - 25MG/5ML, SUSPENSION;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

Suppliers, 36 Kerry, 29 Roquette, 15 BASF, 15 Corel Pharma Chem, 15 Microlex e.U, 10 Sigachi Industries, 9 Gangwal Chemicals, 9 Gangwal Healthcare, 8 Seppic, 7 SPI Pharma, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 DKSH, 6 Lonza Capsugel, 6 Ideal Cures Pvt Ltd, 5 Actylis, 5 Rochem International Inc, 5 DFE Pharma, 5 Lubrizol Life Science Health, 4 ACG Worldwide, 4 Kima Chemical, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 The Dow Chemical Company, 3 Nanjing Well Pharmaceutical, 2 Qualicaps, 2 Pharmatrans-Sanaq, 2 Aeon Procare, 2 Prachin Chemical, 2 Ingredion Pharma Solutions, 2 Vasa Pharmachem, 1 Pfanstiehl, 1 Zhejiang Huakang Pharmaceutical, 1 Pharm-RX Chemical, 1 Bioplus Life Sciences, 1 Boai NKY Pharmaceuticals Ltd, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Finar, 1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 34 Controlled & Modified Release, 33 Direct Compression, 28 Thickeners and Stabilizers, 22 Granulation, 22 Taste Masking, 18 Solubilizers, 18 Film Formers & Plasticizers, 15 Lubricants & Glidants, 14 Disintegrants & Superdisintegrants, 13 Co-Processed Excipients, 11 Topical, 9 Empty Capsules, 9 Chewable & Orodispersible Aids, 8 Parenteral, 5 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Emulsifying Agents, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 13 Finished Drug Prices

MARKET PLACE

25 APIs, 10 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 2 USP Standards, 3 Other Ref. Standards

DIGITAL CONTENT

2 Data Compilation & Company Tracker #PharmaFlow, 28 News

List of USP reference standards related to MolPort-001-018-217

MolPort-001-018-217

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

54 Suppliers

34 USDMF

15 CEP/COS

6 EU WC

27 NDC API

20 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

3 Suppliers

DOSSIERs // Finished Dosage Forms

121 Dossiers

70 FDA Orange Book

18 Europe

6 Canada

6 Australia

4 South Africa

17 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - 100MG

CAPSULE;ORAL - 25MG

CAPSULE;ORAL - 50MG

CAPSULE;ORAL - 75MG;25MG

SUSPENSION;ORAL - 25MG/5ML

SUSPENSION;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

Suppliers

36 Kerry

29 Roquette

15 BASF

15 Corel Pharma Chem

15 Microlex e.U

10 Sigachi Industries

9 Gangwal Chemicals

9 Gangwal Healthcare

8 Seppic

7 SPI Pharma

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 DKSH

6 Lonza Capsugel

6 Ideal Cures Pvt Ltd

5 Actylis

5 Rochem International Inc

5 DFE Pharma

5 Lubrizol Life Science Health

4 ACG Worldwide

4 Kima Chemical

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 The Dow Chemical Company

3 Nanjing Well Pharmaceutical

2 Qualicaps

2 Pharmatrans-Sanaq

2 Aeon Procare

2 Prachin Chemical

2 Ingredion Pharma Solutions

2 Vasa Pharmachem

1 Pfanstiehl

1 Zhejiang Huakang Pharmaceutical

1 Pharm-RX Chemical

1 Bioplus Life Sciences

1 Boai NKY Pharmaceuticals Ltd

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Finar

1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

72 Fillers, Diluents & Binders

53 Coating Systems & Additives

34 Controlled & Modified Release